nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Hypokinesia—Niacin—atherosclerosis	0.0183	0.0309	CcSEcCtD
Levorphanol—Amnesia—Rosuvastatin—atherosclerosis	0.0131	0.0221	CcSEcCtD
Levorphanol—Amnesia—Lovastatin—atherosclerosis	0.0111	0.0188	CcSEcCtD
Levorphanol—Amnesia—Ezetimibe—atherosclerosis	0.0109	0.0184	CcSEcCtD
Levorphanol—Abnormal vision—Niacin—atherosclerosis	0.0108	0.0182	CcSEcCtD
Levorphanol—Amnesia—Simvastatin—atherosclerosis	0.0104	0.0175	CcSEcCtD
Levorphanol—Amnesia—Pravastatin—atherosclerosis	0.00939	0.0159	CcSEcCtD
Levorphanol—Diplopia—Pravastatin—atherosclerosis	0.00882	0.0149	CcSEcCtD
Levorphanol—Affect lability—Pravastatin—atherosclerosis	0.00868	0.0147	CcSEcCtD
Levorphanol—Urinary retention—Niacin—atherosclerosis	0.00852	0.0144	CcSEcCtD
Levorphanol—Mood swings—Pravastatin—atherosclerosis	0.00836	0.0141	CcSEcCtD
Levorphanol—Arrhythmia—Rosuvastatin—atherosclerosis	0.00761	0.0128	CcSEcCtD
Levorphanol—Dysuria—Pravastatin—atherosclerosis	0.00713	0.012	CcSEcCtD
Levorphanol—Flushing—Lovastatin—atherosclerosis	0.0067	0.0113	CcSEcCtD
Levorphanol—Sweating—Niacin—atherosclerosis	0.00662	0.0112	CcSEcCtD
Levorphanol—Flushing—Ezetimibe—atherosclerosis	0.00657	0.0111	CcSEcCtD
Levorphanol—Flushing—Simvastatin—atherosclerosis	0.00627	0.0106	CcSEcCtD
Levorphanol—Confusional state—Rosuvastatin—atherosclerosis	0.0061	0.0103	CcSEcCtD
Levorphanol—Muscle spasms—Lovastatin—atherosclerosis	0.00604	0.0102	CcSEcCtD
Levorphanol—Visual impairment—Niacin—atherosclerosis	0.00597	0.0101	CcSEcCtD
Levorphanol—Muscle spasms—Ezetimibe—atherosclerosis	0.00593	0.01	CcSEcCtD
Levorphanol—Visual impairment—Pravastatin—atherosclerosis	0.00588	0.00993	CcSEcCtD
Levorphanol—Flushing—Niacin—atherosclerosis	0.00575	0.00972	CcSEcCtD
Levorphanol—Flushing—Pravastatin—atherosclerosis	0.00566	0.00957	CcSEcCtD
Levorphanol—Muscle spasms—Simvastatin—atherosclerosis	0.00565	0.00954	CcSEcCtD
Levorphanol—Arrhythmia—Niacin—atherosclerosis	0.00554	0.00935	CcSEcCtD
Levorphanol—Insomnia—Rosuvastatin—atherosclerosis	0.00547	0.00924	CcSEcCtD
Levorphanol—Arrhythmia—Pravastatin—atherosclerosis	0.00545	0.00921	CcSEcCtD
Levorphanol—Palpitations—Ezetimibe—atherosclerosis	0.00545	0.0092	CcSEcCtD
Levorphanol—Dyspepsia—Rosuvastatin—atherosclerosis	0.00533	0.00899	CcSEcCtD
Levorphanol—Tension—Niacin—atherosclerosis	0.0053	0.00894	CcSEcCtD
Levorphanol—Nervousness—Niacin—atherosclerosis	0.00524	0.00885	CcSEcCtD
Levorphanol—Dry mouth—Lovastatin—atherosclerosis	0.00523	0.00883	CcSEcCtD
Levorphanol—Tension—Pravastatin—atherosclerosis	0.00521	0.0088	CcSEcCtD
Levorphanol—Muscle spasms—Niacin—atherosclerosis	0.00519	0.00876	CcSEcCtD
Levorphanol—Constipation—Rosuvastatin—atherosclerosis	0.00517	0.00874	CcSEcCtD
Levorphanol—Confusional state—Lovastatin—atherosclerosis	0.00517	0.00873	CcSEcCtD
Levorphanol—Nervousness—Pravastatin—atherosclerosis	0.00516	0.00871	CcSEcCtD
Levorphanol—Dry mouth—Ezetimibe—atherosclerosis	0.00513	0.00866	CcSEcCtD
Levorphanol—Muscle spasms—Pravastatin—atherosclerosis	0.00511	0.00863	CcSEcCtD
Levorphanol—Confusional state—Ezetimibe—atherosclerosis	0.00507	0.00856	CcSEcCtD
Levorphanol—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00499	0.00842	CcSEcCtD
Levorphanol—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00495	0.00836	CcSEcCtD
Levorphanol—Estrone—ESR2—atherosclerosis	0.00492	0.301	CrCbGaD
Levorphanol—Confusional state—Simvastatin—atherosclerosis	0.00484	0.00817	CcSEcCtD
Levorphanol—Urticaria—Rosuvastatin—atherosclerosis	0.00481	0.00812	CcSEcCtD
Levorphanol—Abdominal pain—Rosuvastatin—atherosclerosis	0.00478	0.00808	CcSEcCtD
Levorphanol—Palpitations—Niacin—atherosclerosis	0.00477	0.00805	CcSEcCtD
Levorphanol—Insomnia—Lovastatin—atherosclerosis	0.00464	0.00783	CcSEcCtD
Levorphanol—Insomnia—Ezetimibe—atherosclerosis	0.00455	0.00768	CcSEcCtD
Levorphanol—Dyspepsia—Lovastatin—atherosclerosis	0.00451	0.00762	CcSEcCtD
Levorphanol—Dry mouth—Niacin—atherosclerosis	0.00449	0.00759	CcSEcCtD
Levorphanol—Dyspepsia—Ezetimibe—atherosclerosis	0.00443	0.00748	CcSEcCtD
Levorphanol—Constipation—Lovastatin—atherosclerosis	0.00439	0.0074	CcSEcCtD
Levorphanol—Confusional state—Pravastatin—atherosclerosis	0.00437	0.00738	CcSEcCtD
Levorphanol—Insomnia—Simvastatin—atherosclerosis	0.00434	0.00733	CcSEcCtD
Levorphanol—Shock—Niacin—atherosclerosis	0.00433	0.00732	CcSEcCtD
Levorphanol—Constipation—Ezetimibe—atherosclerosis	0.0043	0.00726	CcSEcCtD
Levorphanol—Tachycardia—Niacin—atherosclerosis	0.0043	0.00726	CcSEcCtD
Levorphanol—Pruritus—Rosuvastatin—atherosclerosis	0.00428	0.00723	CcSEcCtD
Levorphanol—Hyperhidrosis—Niacin—atherosclerosis	0.00426	0.00719	CcSEcCtD
Levorphanol—Feeling abnormal—Lovastatin—atherosclerosis	0.00423	0.00714	CcSEcCtD
Levorphanol—Dyspepsia—Simvastatin—atherosclerosis	0.00422	0.00713	CcSEcCtD
Levorphanol—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00419	0.00708	CcSEcCtD
Levorphanol—Hyperhidrosis—Pravastatin—atherosclerosis	0.00419	0.00708	CcSEcCtD
Levorphanol—Feeling abnormal—Ezetimibe—atherosclerosis	0.00414	0.007	CcSEcCtD
Levorphanol—Hypotension—Niacin—atherosclerosis	0.00412	0.00695	CcSEcCtD
Levorphanol—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00411	0.00695	CcSEcCtD
Levorphanol—Constipation—Simvastatin—atherosclerosis	0.0041	0.00693	CcSEcCtD
Levorphanol—Urticaria—Lovastatin—atherosclerosis	0.00407	0.00688	CcSEcCtD
Levorphanol—Abdominal pain—Lovastatin—atherosclerosis	0.00405	0.00685	CcSEcCtD
Levorphanol—Dizziness—Rosuvastatin—atherosclerosis	0.004	0.00676	CcSEcCtD
Levorphanol—Urticaria—Ezetimibe—atherosclerosis	0.004	0.00675	CcSEcCtD
Levorphanol—Insomnia—Niacin—atherosclerosis	0.00398	0.00673	CcSEcCtD
Levorphanol—Abdominal pain—Ezetimibe—atherosclerosis	0.00398	0.00671	CcSEcCtD
Levorphanol—Feeling abnormal—Simvastatin—atherosclerosis	0.00395	0.00667	CcSEcCtD
Levorphanol—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00392	0.00662	CcSEcCtD
Levorphanol—Insomnia—Pravastatin—atherosclerosis	0.00392	0.00662	CcSEcCtD
Levorphanol—Dyspepsia—Niacin—atherosclerosis	0.00388	0.00655	CcSEcCtD
Levorphanol—Dyspepsia—Pravastatin—atherosclerosis	0.00382	0.00645	CcSEcCtD
Levorphanol—Rash—Rosuvastatin—atherosclerosis	0.00382	0.00644	CcSEcCtD
Levorphanol—Dermatitis—Rosuvastatin—atherosclerosis	0.00381	0.00644	CcSEcCtD
Levorphanol—Urticaria—Simvastatin—atherosclerosis	0.00381	0.00643	CcSEcCtD
Levorphanol—Abdominal pain—Simvastatin—atherosclerosis	0.00379	0.0064	CcSEcCtD
Levorphanol—Estradiol—ESR2—atherosclerosis	0.00373	0.228	CrCbGaD
Levorphanol—Constipation—Pravastatin—atherosclerosis	0.00371	0.00626	CcSEcCtD
Levorphanol—Pruritus—Lovastatin—atherosclerosis	0.00363	0.00613	CcSEcCtD
Levorphanol—Gastrointestinal pain—Niacin—atherosclerosis	0.0036	0.00608	CcSEcCtD
Levorphanol—Nausea—Rosuvastatin—atherosclerosis	0.00359	0.00607	CcSEcCtD
Levorphanol—Feeling abnormal—Pravastatin—atherosclerosis	0.00357	0.00603	CcSEcCtD
Levorphanol—Pruritus—Ezetimibe—atherosclerosis	0.00356	0.00601	CcSEcCtD
Levorphanol—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00355	0.00599	CcSEcCtD
Levorphanol—Urticaria—Niacin—atherosclerosis	0.0035	0.00591	CcSEcCtD
Levorphanol—Abdominal pain—Niacin—atherosclerosis	0.00348	0.00588	CcSEcCtD
Levorphanol—Urticaria—Pravastatin—atherosclerosis	0.00344	0.00582	CcSEcCtD
Levorphanol—Abdominal pain—Pravastatin—atherosclerosis	0.00343	0.00579	CcSEcCtD
Levorphanol—Pruritus—Simvastatin—atherosclerosis	0.00339	0.00573	CcSEcCtD
Levorphanol—Dizziness—Lovastatin—atherosclerosis	0.00339	0.00573	CcSEcCtD
Levorphanol—Dizziness—Ezetimibe—atherosclerosis	0.00333	0.00562	CcSEcCtD
Levorphanol—Vomiting—Lovastatin—atherosclerosis	0.00326	0.00551	CcSEcCtD
Levorphanol—Rash—Lovastatin—atherosclerosis	0.00323	0.00546	CcSEcCtD
Levorphanol—Dermatitis—Lovastatin—atherosclerosis	0.00323	0.00545	CcSEcCtD
Levorphanol—Vomiting—Ezetimibe—atherosclerosis	0.0032	0.0054	CcSEcCtD
Levorphanol—Dizziness—Simvastatin—atherosclerosis	0.00317	0.00536	CcSEcCtD
Levorphanol—Rash—Ezetimibe—atherosclerosis	0.00317	0.00536	CcSEcCtD
Levorphanol—Dermatitis—Ezetimibe—atherosclerosis	0.00317	0.00535	CcSEcCtD
Levorphanol—Pruritus—Niacin—atherosclerosis	0.00312	0.00526	CcSEcCtD
Levorphanol—Pruritus—Pravastatin—atherosclerosis	0.00307	0.00518	CcSEcCtD
Levorphanol—Vomiting—Simvastatin—atherosclerosis	0.00305	0.00515	CcSEcCtD
Levorphanol—Nausea—Lovastatin—atherosclerosis	0.00305	0.00514	CcSEcCtD
Levorphanol—Estrone—ESR1—atherosclerosis	0.00303	0.185	CrCbGaD
Levorphanol—Rash—Simvastatin—atherosclerosis	0.00302	0.00511	CcSEcCtD
Levorphanol—Dermatitis—Simvastatin—atherosclerosis	0.00302	0.0051	CcSEcCtD
Levorphanol—Nausea—Ezetimibe—atherosclerosis	0.00299	0.00504	CcSEcCtD
Levorphanol—Dizziness—Niacin—atherosclerosis	0.00291	0.00492	CcSEcCtD
Levorphanol—Dizziness—Pravastatin—atherosclerosis	0.00287	0.00484	CcSEcCtD
Levorphanol—Nausea—Simvastatin—atherosclerosis	0.00285	0.00481	CcSEcCtD
Levorphanol—Vomiting—Niacin—atherosclerosis	0.0028	0.00473	CcSEcCtD
Levorphanol—Rash—Niacin—atherosclerosis	0.00278	0.00469	CcSEcCtD
Levorphanol—Dermatitis—Niacin—atherosclerosis	0.00277	0.00468	CcSEcCtD
Levorphanol—Vomiting—Pravastatin—atherosclerosis	0.00276	0.00466	CcSEcCtD
Levorphanol—Rash—Pravastatin—atherosclerosis	0.00273	0.00462	CcSEcCtD
Levorphanol—Dermatitis—Pravastatin—atherosclerosis	0.00273	0.00461	CcSEcCtD
Levorphanol—Nausea—Niacin—atherosclerosis	0.00262	0.00442	CcSEcCtD
Levorphanol—Nausea—Pravastatin—atherosclerosis	0.00258	0.00435	CcSEcCtD
Levorphanol—Estradiol—ESR1—atherosclerosis	0.0023	0.141	CrCbGaD
Levorphanol—Estrone—ALB—atherosclerosis	0.00135	0.0826	CrCbGaD
Levorphanol—Estradiol—ALB—atherosclerosis	0.00102	0.0626	CrCbGaD
Levorphanol—OPRK1—Signaling by GPCR—EDNRA—atherosclerosis	0.000423	0.00108	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CCR2—atherosclerosis	0.000423	0.00108	CbGpPWpGaD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000422	0.00108	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—AGT—atherosclerosis	0.000417	0.00107	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—KNG1—atherosclerosis	0.000413	0.00106	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—GHRL—atherosclerosis	0.000413	0.00105	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—UTS2—atherosclerosis	0.000411	0.00105	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AGTR1—atherosclerosis	0.000411	0.00105	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—CCL2—atherosclerosis	0.000407	0.00104	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCL4—atherosclerosis	0.000405	0.00103	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—KNG1—atherosclerosis	0.000399	0.00102	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000396	0.00101	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCL3—atherosclerosis	0.000396	0.00101	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CX3CR1—atherosclerosis	0.000394	0.00101	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CASR—atherosclerosis	0.000394	0.00101	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—EDNRA—atherosclerosis	0.000394	0.00101	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CCR2—atherosclerosis	0.000394	0.00101	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CX3CL1—atherosclerosis	0.000387	0.000988	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—F2—atherosclerosis	0.000385	0.000985	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—GHRL—atherosclerosis	0.000384	0.000981	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—EDN1—atherosclerosis	0.000383	0.000979	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CCL5—atherosclerosis	0.00038	0.000972	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APOA2—atherosclerosis	0.000378	0.000966	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APOA4—atherosclerosis	0.000371	0.000949	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CNR2—atherosclerosis	0.000367	0.000937	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—CXCL8—atherosclerosis	0.000367	0.000936	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—MMP3—atherosclerosis	0.000366	0.000935	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—KNG1—atherosclerosis	0.000362	0.000925	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000362	0.000924	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—UTS2—atherosclerosis	0.000361	0.000922	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AGTR1—atherosclerosis	0.00036	0.00092	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCR2—atherosclerosis	0.000358	0.000914	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—EDNRA—atherosclerosis	0.000358	0.000914	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000357	0.000911	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—GHRL—atherosclerosis	0.000349	0.000891	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—EDN1—atherosclerosis	0.000348	0.000889	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CX3CR1—atherosclerosis	0.000346	0.000884	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CASR—atherosclerosis	0.000346	0.000884	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CCL5—atherosclerosis	0.000345	0.000882	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CCL2—atherosclerosis	0.000344	0.000878	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCL4—atherosclerosis	0.000342	0.000874	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CX3CL1—atherosclerosis	0.000339	0.000867	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—KNG1—atherosclerosis	0.000337	0.000861	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—EDN1—atherosclerosis	0.000336	0.000859	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000335	0.000856	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CCL5—atherosclerosis	0.000333	0.000852	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PRKCG—atherosclerosis	0.000328	0.000839	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—VWF—atherosclerosis	0.000327	0.000835	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—APOC3—atherosclerosis	0.000325	0.00083	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—LDLR—atherosclerosis	0.000323	0.000825	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CNR2—atherosclerosis	0.000322	0.000822	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—CXCL8—atherosclerosis	0.000321	0.000821	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—MMP3—atherosclerosis	0.000321	0.00082	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APOA2—atherosclerosis	0.00032	0.000817	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—AGT—atherosclerosis	0.000318	0.000813	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000317	0.00081	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCL3—atherosclerosis	0.000315	0.000806	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—KNG1—atherosclerosis	0.000306	0.000782	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—EDN1—atherosclerosis	0.000305	0.00078	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—UTS2—atherosclerosis	0.000305	0.000779	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AGTR1—atherosclerosis	0.000304	0.000777	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CCL5—atherosclerosis	0.000303	0.000774	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NCF1—atherosclerosis	0.000302	0.000772	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—F2—atherosclerosis	0.000294	0.000751	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CX3CR1—atherosclerosis	0.000292	0.000747	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CASR—atherosclerosis	0.000292	0.000747	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AGT—atherosclerosis	0.000289	0.000738	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PRKCG—atherosclerosis	0.000288	0.000735	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CX3CL1—atherosclerosis	0.000287	0.000732	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—VWF—atherosclerosis	0.000287	0.000732	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCR2—atherosclerosis	0.000285	0.000729	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EDNRA—atherosclerosis	0.000285	0.000729	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APOC3—atherosclerosis	0.000285	0.000728	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—EDN1—atherosclerosis	0.000284	0.000726	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CYBA—atherosclerosis	0.000284	0.000725	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—LDLR—atherosclerosis	0.000283	0.000723	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CCL5—atherosclerosis	0.000282	0.00072	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000281	0.000719	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AGT—atherosclerosis	0.000279	0.000713	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PLAT—atherosclerosis	0.000278	0.00071	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—GHRL—atherosclerosis	0.000278	0.00071	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PARP1—atherosclerosis	0.000278	0.00071	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCL3—atherosclerosis	0.000277	0.000706	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CNR2—atherosclerosis	0.000272	0.000694	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CXCL8—atherosclerosis	0.000272	0.000694	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—MMP3—atherosclerosis	0.000271	0.000693	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000268	0.000685	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—F2—atherosclerosis	0.000267	0.000682	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NCF1—atherosclerosis	0.000265	0.000677	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—EDN1—atherosclerosis	0.000258	0.000659	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—F2—atherosclerosis	0.000258	0.000658	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCL5—atherosclerosis	0.000256	0.000654	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000255	0.000653	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AGT—atherosclerosis	0.000253	0.000647	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EDNRA—atherosclerosis	0.00025	0.000639	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCR2—atherosclerosis	0.00025	0.000639	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CYBA—atherosclerosis	0.000249	0.000636	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000247	0.00063	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—KNG1—atherosclerosis	0.000244	0.000623	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PARP1—atherosclerosis	0.000244	0.000623	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PLAT—atherosclerosis	0.000244	0.000623	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—GHRL—atherosclerosis	0.000244	0.000623	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PRKCG—atherosclerosis	0.000243	0.000622	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AGTR1—atherosclerosis	0.000243	0.00062	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—VWF—atherosclerosis	0.000242	0.000619	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APOC3—atherosclerosis	0.000241	0.000615	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—LDLR—atherosclerosis	0.000239	0.000611	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CCL2—atherosclerosis	0.000238	0.000608	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PLG—atherosclerosis	0.000236	0.000604	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AGT—atherosclerosis	0.000236	0.000602	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—F2—atherosclerosis	0.000234	0.000598	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCL3—atherosclerosis	0.000234	0.000597	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000224	0.000572	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NCF1—atherosclerosis	0.000224	0.000572	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SOCS3—atherosclerosis	0.000224	0.000572	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—F2—atherosclerosis	0.000218	0.000556	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MMP3—atherosclerosis	0.000216	0.000552	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IGF2—atherosclerosis	0.000215	0.00055	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AGT—atherosclerosis	0.000214	0.000547	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—KNG1—atherosclerosis	0.000214	0.000546	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AGTR1—atherosclerosis	0.000213	0.000543	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCR2—atherosclerosis	0.000211	0.00054	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EDNRA—atherosclerosis	0.000211	0.00054	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CYBA—atherosclerosis	0.00021	0.000538	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—APOB—atherosclerosis	0.000209	0.000534	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CCL2—atherosclerosis	0.000209	0.000533	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000208	0.000533	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PLG—atherosclerosis	0.000207	0.000529	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000207	0.000529	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PARP1—atherosclerosis	0.000206	0.000526	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PLAT—atherosclerosis	0.000206	0.000526	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GHRL—atherosclerosis	0.000206	0.000526	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EDN1—atherosclerosis	0.000206	0.000525	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCL5—atherosclerosis	0.000204	0.000521	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—LPL—atherosclerosis	0.000199	0.00051	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—F2—atherosclerosis	0.000198	0.000505	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SOCS3—atherosclerosis	0.000196	0.000501	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PRKCG—atherosclerosis	0.000194	0.000495	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MMP3—atherosclerosis	0.00019	0.000484	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000189	0.000484	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SPP1—atherosclerosis	0.000189	0.000483	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IGF2—atherosclerosis	0.000189	0.000482	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CXCL8—atherosclerosis	0.000188	0.000481	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APOB—atherosclerosis	0.000183	0.000468	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000182	0.000464	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—KNG1—atherosclerosis	0.000181	0.000462	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EDN1—atherosclerosis	0.00018	0.000461	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AGTR1—atherosclerosis	0.00018	0.000459	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCL5—atherosclerosis	0.000179	0.000457	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CCL2—atherosclerosis	0.000176	0.00045	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PLG—atherosclerosis	0.000175	0.000447	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—LPL—atherosclerosis	0.000175	0.000447	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PDGFB—atherosclerosis	0.000175	0.000447	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AGT—atherosclerosis	0.000171	0.000436	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PRKCG—atherosclerosis	0.00017	0.000434	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—LEP—atherosclerosis	0.000167	0.000427	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—APOE—atherosclerosis	0.000167	0.000427	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SOCS3—atherosclerosis	0.000166	0.000424	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CAV1—atherosclerosis	0.000166	0.000423	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SPP1—atherosclerosis	0.000166	0.000423	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—APOA1—atherosclerosis	0.000165	0.000422	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CXCL8—atherosclerosis	0.000165	0.000421	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MMP3—atherosclerosis	0.00016	0.000409	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ESR1—atherosclerosis	0.00016	0.000408	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IGF2—atherosclerosis	0.000159	0.000407	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—F2—atherosclerosis	0.000158	0.000403	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APOB—atherosclerosis	0.000155	0.000396	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000154	0.000392	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PDGFB—atherosclerosis	0.000153	0.000392	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EDN1—atherosclerosis	0.000152	0.000389	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCL5—atherosclerosis	0.000151	0.000386	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CG—atherosclerosis	0.000151	0.000386	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AGT—atherosclerosis	0.00015	0.000382	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—LPL—atherosclerosis	0.000148	0.000378	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—LEP—atherosclerosis	0.000147	0.000375	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APOE—atherosclerosis	0.000147	0.000375	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CAV1—atherosclerosis	0.000145	0.000371	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APOA1—atherosclerosis	0.000145	0.00037	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—MAPK3—atherosclerosis	0.000145	0.000369	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PRKCG—atherosclerosis	0.000144	0.000367	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—INS—atherosclerosis	0.000143	0.000365	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCL2—atherosclerosis	0.000141	0.000359	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SPP1—atherosclerosis	0.00014	0.000358	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ESR1—atherosclerosis	0.00014	0.000358	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CXCL8—atherosclerosis	0.000139	0.000356	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—F2—atherosclerosis	0.000138	0.000353	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IGF1—atherosclerosis	0.000138	0.000353	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CG—atherosclerosis	0.000132	0.000338	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SERPINE1—atherosclerosis	0.000131	0.000335	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PDGFB—atherosclerosis	0.00013	0.000331	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—MAPK3—atherosclerosis	0.000127	0.000324	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AGT—atherosclerosis	0.000126	0.000323	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NOS3—atherosclerosis	0.000125	0.00032	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—INS—atherosclerosis	0.000125	0.00032	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—LEP—atherosclerosis	0.000124	0.000317	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APOE—atherosclerosis	0.000124	0.000317	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCL2—atherosclerosis	0.000123	0.000315	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CAV1—atherosclerosis	0.000123	0.000314	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APOA1—atherosclerosis	0.000122	0.000313	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IGF1—atherosclerosis	0.000121	0.00031	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ESR1—atherosclerosis	0.000118	0.000302	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—F2—atherosclerosis	0.000117	0.000299	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SERPINE1—atherosclerosis	0.000115	0.000294	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CG—atherosclerosis	0.000112	0.000286	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CXCL8—atherosclerosis	0.000111	0.000284	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NOS3—atherosclerosis	0.00011	0.000281	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—AKT1—atherosclerosis	0.000107	0.000274	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—MAPK3—atherosclerosis	0.000107	0.000274	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—INS—atherosclerosis	0.000106	0.00027	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL6—atherosclerosis	0.000106	0.00027	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCL2—atherosclerosis	0.000104	0.000266	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IGF1—atherosclerosis	0.000102	0.000262	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MMP9—atherosclerosis	0.000101	0.000257	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NFKB1—atherosclerosis	9.94e-05	0.000254	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MAPK8—atherosclerosis	9.77e-05	0.00025	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AKT1—atherosclerosis	9.75e-05	0.000249	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CXCL8—atherosclerosis	9.74e-05	0.000249	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SERPINE1—atherosclerosis	9.72e-05	0.000248	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AKT1—atherosclerosis	9.41e-05	0.00024	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NOS3—atherosclerosis	9.28e-05	0.000237	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL6—atherosclerosis	9.26e-05	0.000237	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—VEGFA—atherosclerosis	9.02e-05	0.000231	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—STAT3—atherosclerosis	8.94e-05	0.000228	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MMP9—atherosclerosis	8.81e-05	0.000225	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NFKB1—atherosclerosis	8.72e-05	0.000223	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MAPK8—atherosclerosis	8.57e-05	0.000219	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AKT1—atherosclerosis	8.55e-05	0.000218	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MAPK3—atherosclerosis	8.54e-05	0.000218	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TGFB1—atherosclerosis	8.28e-05	0.000212	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CXCL8—atherosclerosis	8.23e-05	0.00021	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AKT1—atherosclerosis	7.95e-05	0.000203	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—VEGFA—atherosclerosis	7.91e-05	0.000202	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—STAT3—atherosclerosis	7.84e-05	0.0002	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL6—atherosclerosis	7.83e-05	0.0002	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MAPK3—atherosclerosis	7.49e-05	0.000191	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MMP9—atherosclerosis	7.45e-05	0.00019	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NFKB1—atherosclerosis	7.37e-05	0.000188	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TGFB1—atherosclerosis	7.26e-05	0.000186	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MAPK8—atherosclerosis	7.24e-05	0.000185	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AKT1—atherosclerosis	7.22e-05	0.000185	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—VEGFA—atherosclerosis	6.69e-05	0.000171	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—STAT3—atherosclerosis	6.62e-05	0.000169	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MAPK3—atherosclerosis	6.33e-05	0.000162	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL6—atherosclerosis	6.24e-05	0.000159	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TGFB1—atherosclerosis	6.14e-05	0.000157	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AKT1—atherosclerosis	5.76e-05	0.000147	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL6—atherosclerosis	5.47e-05	0.00014	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AKT1—atherosclerosis	5.05e-05	0.000129	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL6—atherosclerosis	4.63e-05	0.000118	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AKT1—atherosclerosis	4.27e-05	0.000109	CbGpPWpGaD
